PO-1058 Long-term outcomes of LDR compared to hypofractionated EBRT for intermediate-risk prostate cancer. (April 2019) - Sanmamed Salgado, N.; Joseph, L.; Crook, J.; Borg, J.; Chung, P.; Warde, P.; Di Tomasso, A.; Berlin, A.; Patel, M.; Bayley, A.; Catton, C.; Helou, J.